Infosys (INFY) Stock Forecast & Price Target

Infosys is well positioned by resilient demand in Financial Services, where despite more cautious discretionary spending amid geopol instability, growth is still expected to run above company average. The business is benefiting from strong momentum in banking, payments, capital markets, and wealth management, with AI, efficiency, and modernization driving a $1B large-deal TCV in the vertical and supporting net new TCV growth through rising GCC demand. Its outlook is further strengthened by accretive acquisitions, including Optimum Health and Stratus, which add roughly $50mn and $10mn to F1Q revenue respectively, while Versent could contribute another ~$35-$45mn annually once closed.

Infosys is facing a weaker fundamental backdrop as client-specific disruptions, macro uncertainty, discretionary spending cuts, and aggressive pricing have all slowed revenue conversion despite solid AI demand and large deal traction. The company’s FY27 growth guide was cut to 1.5%-3.0% constant currency, with only 0.6% organic growth implied at the midpoint after a 1.7% inorganic contribution, and 1Q27 revenue growth of +2.4% cc was below Street expectations. Longer term, AI-led productivity, offshore delivery headwinds, and contract losses in Energy/Utilities and European auto suggest margin support may not be enough to offset muted net growth, leaving recovery dependent on multi-year improvement.